Your browser doesn't support javascript.
loading
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Pogue, Jason M; Jones, Ronald N; Bradley, John S; Andes, David R; Bhavnani, Sujata M; Drusano, George L; Dudley, Michael N; Flamm, Robert K; Rodvold, Keith A; Ambrose, Paul G.
  • Pogue JM; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA jmpogue@med.umich.edu.
  • Jones RN; USCAST, Silverton, Oregon, USA.
  • Bradley JS; University of San Diego, San Diego, California, USA.
  • Andes DR; Rady Children's Hospital, San Diego, California, USA.
  • Bhavnani SM; University of Wisconsin, Madison, Wisconsin, USA.
  • Drusano GL; ICPD, Schenectady, New York, USA.
  • Dudley MN; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, Florida, USA.
  • Flamm RK; Qpex Biopharma, San Diego, California, USA.
  • Rodvold KA; JMI Laboratories, North Liberty, Iowa, USA.
  • Ambrose PG; University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA.
Article en En | MEDLINE | ID: mdl-31767718
ABSTRACT
The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae are considered susceptible at MIC values of ≤2 mg/liter. These recommendations are contingent upon dosing and testing strategies that are described in this commentary. Importantly, these recommendations are not applicable to lower respiratory tract infections, for which we recommend no breakpoints. Furthermore, there is no breakpoint recommendation for polymyxin B for lower urinary tract infections.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Polimixinas / Antibacterianos Tipo de estudio: Guideline Límite: Humans País como asunto: America do norte Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Polimixinas / Antibacterianos Tipo de estudio: Guideline Límite: Humans País como asunto: America do norte Idioma: En Año: 2020 Tipo del documento: Article